New sleep drug enters testing to help people stay asleep
NCT ID NCT07420816
Summary
This study aims to see if a new medication called APSTZD can help people with chronic insomnia stay asleep better. It will compare APSTZD to an existing insomnia drug and a placebo (inactive pill) in 222 adults. Researchers will measure how much time people spend awake after initially falling asleep and track any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSOMNIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UNIFAG - Casa Nossa Senhora da PAZ -ASF
Bragança Paulista, São Paulo, 12916-900, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.